![](/img/cover-not-exists.png)
Cost and Utilization Outcomes After Exclusion of Dipeptidyl Peptidase-4 Inhibitors and Other Diabetes Drug Category Changes in a Self-Funded, State Employee Managed Care Plan
King, Jarrod, McAdam-Marx, Carrie, McCaleb, Rachael, Davis, Dwight, Bemberg, Geri Beth, Johnson, Jill T.Volume:
25
Language:
english
Journal:
Journal of Managed Care & Specialty Pharmacy
DOI:
10.18553/jmcp.2019.25.6.646
Date:
June, 2019
File:
PDF, 186 KB
english, 2019